Sun Pharma & Moebius Medical announce dual publications on MM-II’s phase 2b trial results and mechanism of action in ...
Sun Pharma and Israel-based Moebius Medical Limited announced the publication of two articles in osteoarthritis and cartilage, the official journal of the Osteoarthritis Research Society International (OARSI), highlighting MM-II, a novel non-opioid product …